Biosintesis

Biosintesis

THE BEST SOLUTION IN INNOVATION AND PRECLINICAL AND CLINICAL RESEARCH

Operating since 2008, Biosintesis is a 100% Brazilian company, created to offer to the market the most advanced research development and innovation solutions in the areas of:

 

Evaluation of new molecules and materials

Biological studies in vitro

that contemplate the toxicological, preclinical and clinical studies

 

The company has distinguished itself by investment in R&D, that add R$ 2 million in the last years and that enabled the creation of our research and development center located at IPEN/USP. Having the premise to state-of-the-art technology, flexibility and the quality, we have a highly qualified team besides pioneer equipment and protocols in Brazil.

 

We believe in innovative force centered in initial process of development of health products, besides of its huge collaboration regarding research and development focused on human and bioethics potential, with the ultimate goal of ensuring human health.

 

Biosintesis focus its activities in preclinical evaluation and development of bioassays relating to toxic potential of the components and materials that compose the pharmaceutical products, cosmetics, medical-hospital minimizing the risks of adverse effects and ensuring the efficacy, safety and compliance of each product and device.